• Maintain Underperform with target price of Rs 4,200
• Q4 results: Operationally in line, hospital profitability declines
• PAT miss was driven by higher depreciation and amortisation expenses
• Hospital business EBITDA margin compressed 130 bps YoY and 70 bps QoQ to 23.1%
Comments
Post a Comment